These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 19427445)

  • 1. Relation of resting heart rate to prognosis in patients with idiopathic pulmonary arterial hypertension.
    Henkens IR; Van Wolferen SA; Gan CT; Boonstra A; Swenne CA; Twisk JW; Kamp O; van der Wall EE; Schalij MJ; Vonk-Noordegraaf A; Vliegen HW
    Am J Cardiol; 2009 May; 103(10):1451-6. PubMed ID: 19427445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
    Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
    Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of heart rate as an independent predictor for survival after heart transplantation.
    Anand RG; Reddy MT; Yau CL; Myers L; Amin RR; Stahls PF; Dumas D; Frohlich ED; Ventura HO
    Am J Cardiol; 2009 May; 103(9):1290-4. PubMed ID: 19406274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of serum creatinine with abnormal hemodynamics and mortality in pulmonary arterial hypertension.
    Shah SJ; Thenappan T; Rich S; Tian L; Archer SL; Gomberg-Maitland M
    Circulation; 2008 May; 117(19):2475-83. PubMed ID: 18458173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension.
    Ruiz-Cano MJ; Escribano P; Alonso R; Delgado J; Carreira P; Velazquez T; Sanchez MA; Sáenz de la Calzada C
    J Heart Lung Transplant; 2009 Jun; 28(6):621-7. PubMed ID: 19481024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of heart rate recovery and peak oxygen consumption for long-term mortality in patients with coronary heart disease.
    Aijaz B; Squires RW; Thomas RJ; Johnson BD; Allison TG
    Am J Cardiol; 2009 Jun; 103(12):1641-6. PubMed ID: 19539069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of workload at the heart rate of 100 beats/min in predicting cardiovascular mortality in men aged 42, 48, 54, or 60 years at baseline.
    Savonen KP; Lakka TA; Laukkanen JA; Rauramaa TH; Salonen JT; Rauramaa R
    Am J Cardiol; 2007 Aug; 100(4):563-8. PubMed ID: 17697806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of heart rate at rest and long-term (>20 years) death rate in initially healthy middle-aged men.
    Jouven X; Empana JP; Escolano S; Buyck JF; Tafflet M; Desnos M; Ducimetière P
    Am J Cardiol; 2009 Jan; 103(2):279-83. PubMed ID: 19121452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.
    Modrykamien AM; Gudavalli R; McCarthy K; Parambil J
    Respir Care; 2010 May; 55(5):584-8. PubMed ID: 20420729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease.
    Trad S; Amoura Z; Beigelman C; Haroche J; Costedoat N; Boutin le TH; Cacoub P; Frances C; Wechsler B; Grenier P; Piette JC
    Arthritis Rheum; 2006 Jan; 54(1):184-91. PubMed ID: 16385514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between achieved heart rate and outcomes in patients with atrial fibrillation (from the Atrial Fibrillation Follow-up Investigation of Rhythm Management [AFFIRM] Study).
    Cooper HA; Bloomfield DA; Bush DE; Katcher MS; Rawlins M; Sacco JD; Chandler M;
    Am J Cardiol; 2004 May; 93(10):1247-53. PubMed ID: 15135698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise testing to estimate survival in pulmonary hypertension.
    Groepenhoff H; Vonk-Noordegraaf A; Boonstra A; Spreeuwenberg MD; Postmus PE; Bogaard HJ
    Med Sci Sports Exerc; 2008 Oct; 40(10):1725-32. PubMed ID: 18799981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of combined exercise and recovery electrocardiographic analysis.
    Bigi R; Cortigiani L; Gregori D; Bax JJ; Fiorentini C
    Arch Intern Med; 2005 Jun; 165(11):1253-8. PubMed ID: 15956004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordance between microneurographic and heart-rate spectral indices of sympathetic activity in pulmonary arterial hypertension.
    McGowan CL; Swiston JS; Notarius CF; Mak S; Morris BL; Picton PE; Granton JT; Floras JS
    Heart; 2009 May; 95(9):754-8. PubMed ID: 19151012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand.
    Foocharoen C; Nanagara R; Kiatchoosakun S; Suwannaroj S; Mahakkanukrauh A
    Int J Rheum Dis; 2011 Aug; 14(3):282-9. PubMed ID: 21816025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival in schistosomiasis-associated pulmonary arterial hypertension.
    dos Santos Fernandes CJ; Jardim CV; Hovnanian A; Hoette S; Dias BA; Souza S; Humbert M; Souza R
    J Am Coll Cardiol; 2010 Aug; 56(9):715-20. PubMed ID: 20723801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of baseline predictors of prognosis in pulmonary arterial hypertension in patients surviving ≤2 years and those surviving ≥5 years after baseline right-sided cardiac catheterization.
    Batal O; Khatib OF; Dweik RA; Hammel JP; McCarthy K; Minai OA
    Am J Cardiol; 2012 May; 109(10):1514-20. PubMed ID: 22360818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of paradoxical systolic blood pressure increase after exercise as a predictor of cardiovascular mortality.
    Huang CL; Su TC; Chen WJ; Lin LY; Wang WL; Feng MH; Liau CS; Lee YT; Chen MF
    Am J Cardiol; 2008 Sep; 102(5):518-23. PubMed ID: 18721505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and impact of coronary artery disease in patients with pulmonary arterial hypertension.
    Shimony A; Eisenberg MJ; Rudski LG; Schlesinger R; Afilalo J; Joyal D; Dragatakis L; Hirsch A; Boutet K; Fox BD; Langleben D
    Am J Cardiol; 2011 Aug; 108(3):460-4. PubMed ID: 21600533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.